New agent overcomes drug resistance in HER2-positive breast cancer …

This entry was posted by ctbenefits on March 19, 2016 at 2:47 AM

“This result is particularly exciting as it leads us to speculate the CDK4/6 inhibitors might not only help patients with metastatic breast cancer, but could potentially help in earlier stages of the disease where we aim to prevent recurrence of cancer …